Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-25T19:38:52.812Z Has data issue: false hasContentIssue false
  • English
  • Français

Treatment options for acute mania

Published online by Cambridge University Press:  16 April 2020

Pierre Thomas
Pierre Thomas*
Affiliation:
Clinique de psychiatrie Michel-Fontan, CHRU de Lille, Université Lille 2, 6, rue du Pr. Laguesse, 59037 Lille cedex, France
*
*Corresponding author. pthomas@chru-lille.fr (P. Thomas).
Get access

Extract

Mood disorders that have no medical or pharmacological causes are divided into depressive disorders (unipolar, or major depressive disorder) and bipolar disorders. In bipolar disorders, both depressive and manic episodes occur sequentially.

A manic episode is characterised as an abnormally excited mood that is experienced by a patient for a distinct period (at least a week). Diagnosis of mania requires that a patient’s work and social life be significantly affected, or that the patient needs hospitalisation. Diagnosis also requires the presence of three or more of the following symptoms: inflated self-esteem or grandiosity; decreased need for sleep; increased talkativeness; racing thoughts/ideas; distraction; increased goal-directed activity; excessive involvement in pleasurable activities [1].

Type
Research Article
Information
European Psychiatry , Volume 18 , Issue S1 , December 2003 , pp. 13s - 18s
Copyright
Copyright © European Psychiatric Association 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association. Diagnostic and statistical manual of mental disorders: fourth edition. Am Psychiatr Assoc 1994: 317—92.Google Scholar
American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry 2002 159 (4 Suppl): 1–50.Google Scholar
Barbini, BScherillo, PBenedetti, FCrespi, GColombo, CSmeraldi, EResponse to clozapine in acute mania is more rapid than that of chlorpromazme. Int Clin Psychopharmacol 1997, 12 (2): 109–112.CrossRefGoogle Scholar
Berk, MIchim, LBrook, SOlanzapine compared to lithium in mania: a double-blind randomized controlled trial. Int Clin Psychopharmacol 1999; 14 (6): 339–43.CrossRefGoogle Scholar
Bowden, CLBrugger, AMSwann, ACCalabrese, JRJamcak, PGPetty, Fet al.Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mama Study Group. J Am Med Assoc 1994; 271 (12): 918–24.CrossRefGoogle Scholar
Calabrese, JR and Delucchi, GASpectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder. Am J Psychiatry 1990; 147 (4): 431–4.Google Scholar
Calabrese, JRShelton, MDRapport, DJKujawa, MKimmel, SECaban, SCurrent research on rapid cycling bipolar disorder and its treatment. J Aflect Disord 2001; 67 (1–3): 241–55.CrossRefGoogle ScholarPubMed
Emrich, HMDose, M von Zerssen, DThe use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders J Affective Disord 1985; 8 (3): 243–50.CrossRefGoogle Scholar
Freeman, MP and Stoll, ALMood stabilizer combinations: a review of safety and efficacy. Am J Psychiatry 1998; 155(1): 12–21.CrossRefGoogle ScholarPubMed
Freeman, TWClothier, JLPazzagha, PLesem, MDSwann, ACA double-blind comparison of valproate and lithium in the treatment of acute mama. Am J Psychiatry 1992; 149 (1): 108–11.Google Scholar
Frye, MA and Altshuler, LLSelection of initial treatment for bipolar disorder, manic phase. Mod Probi Pharmacopsychiatry 1997; 25: 88–113CrossRefGoogle ScholarPubMed
Frye, MAKetter, TAKimbrell, TADunn, RTSpeer, AMOsuch, EAet al.A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 2000; 20 (6): 607–14.CrossRefGoogle ScholarPubMed
Goodwin, FKMurphy, DLBunney, WELithium-carbonate treatment in depression and mania. A longitudinal double-blind study. Arch Gen Psychiatry 1969; 21 (4): 486–96.CrossRefGoogle Scholar
Green, AlTohen, MPatel, JKBanov, MDurand, CBerman, Iet al.Clozapine in the treatment of refractory psychotic mania. Am J Psychiatry 2000; 157 (6): 982–6.CrossRefGoogle ScholarPubMed
Greil, WKleindienst, NErazo, NMuller-Oerlinghausen, BDifferential response to lithium and carbamazepine in the prophylaxis of bipolar disorder. J Clin Psychopharmacol 1998; 18 (6): 455–60.CrossRefGoogle ScholarPubMed
Grunze, HErfurth, AMarcuse, AAmann, BNormann, CWalden, JTiagabine appears not to be efficacious in the treatment of acute mama. J Clini Psychiatry 1999; 60 (11): 759–62.CrossRefGoogle ScholarPubMed
Grunze, HKasper, SGoodwin, GBowden, CBaldwin, D Licht. et al.The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania. World J Biol Psychiatry 2003; 4 (D.5–13.CrossRefGoogle ScholarPubMed
Ichim, LBerk, MBrook, SLamotrigine compared with lithium in mania: a double-blind randomized controlled trial. Ann Clin Psychiatry 2000; 12(1): 5–10.CrossRefGoogle ScholarPubMed
Kahn, DARoss, RTreatment of bipolar disorder: a guide for patients and families. Postgraduate Medicine 2000.Google Scholar
Kanba, SYagi, GKamijima, KSuzuki, TTajima, OOtaki, JThe first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania. Prog Neuropsychopharmacol Biol Psychiatry 1994; 18 (4) 707–15.Google ScholarPubMed
Letmaier, MSchreinzer, DTypical neuroleptics versus atypical antipsychotics in the treatment of acute mania in a natural setting. Eur Neuropsychopharmacol 2003; 13 (Suppl. 4): S186.CrossRefGoogle Scholar
Keck, PEVersiani, MPotkin, SWest, SAGiller, EIce K Ziprasi-done in the treatment of acute bipolar mania- a three-week, placebo-controlled, double-blind, randomized trial Ziprasidone in Mania Study Group. Am J Psychiatry 2003; 160 (4): 741–8.CrossRefGoogle Scholar
Ketter, TAPazzaglia, PJPost, RMSynergy of carbamazepine and valproic acid in affective illness: case report and review of the literature. J Clin Psychopharmacol 1992; 12 (4): 276–81.Google ScholarPubMed
McElroy, SL and Keck, PEPharmacologic agents for the treatment of acute bipolar mania Biol Psychiatry 2000, 48 (6): 539–57.Google Scholar
McElroy, SLKeck, PEStanton, SPTugrul, KCBennett, JAStrakowski, SMA randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania. J Clin Psychiatry 1996; 57 (4): 142–6.Google ScholarPubMed
Mishory, AYaroslavsky, YBersudsky, YBelmaker, RHPhenytoin as an antimanic anticonvulsant- a controlled study. Am J Psychiatry 2000; 157 (3): 463–5.CrossRefGoogle ScholarPubMed
Moller, HJKissling, WRiehl, TBauml, JBinz, UWendt, GDouble-blind evaluation of the antimanic properties of carbamazepine as a comedication to haloperidol. Prog Neuropsychopharmacol Biol Psychiatry 1989; 13 (1–2): 127–36CrossRefGoogle ScholarPubMed
Muller-Oerlinghausen, BBerghofer, ABauer, MBipolar disorder. Lancet 2002; 359 (9302): 241–7.CrossRefGoogle ScholarPubMed
Muller-Oerlinghausen, BRetzow, AHenn, FAGiedke, HWalden J Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. European Valproate Mania Study Group. J Clin Psychopharmacol 2000; 20 (2): 195–203.CrossRefGoogle ScholarPubMed
Pande, ACCrockatt, JGJanney, CAWerth, JLTsaroucha, GGabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group. Bipolar Disord 2000; 2 (3Pt 2): 249–55.CrossRefGoogle ScholarPubMed
Pope, HGMcElroy, SL Keck PE, JrHudson, JIValproate in the treatment of acute mania. A placebo-controlled study. Arch Gen Psychiatry 1991: 48(1): 62–8.CrossRefGoogle Scholar
Post, RMUhde, TWRoy-Byrne, PPJoffe, RTCorrelates of antimanic response to carbamazepine. Psychiatry Res 1987; 21 (1) 71–83.CrossRefGoogle ScholarPubMed
Schaff, MRFawcett, JZajecka, J.M.Divalproex sodium in the treatment of refractory affective disorders. J Clin Psychiatry 1993; 54 (10): 380–4.Google ScholarPubMed
Schou, MJuel-Nielsen, NStromgren, EVoldby, HThe treatment of mame psychoses by the administration of lithium salts J Neurol Neu-rosurg Psychiat 1954; 17: 250–60.CrossRefGoogle Scholar
Segal, JBerk, MBrook, SRisperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Clin Neuropharmacol 1998; 21 (3): 176–80.Google ScholarPubMed
Shi, LNamjoshi, MAZhang, FGandhi, GEdgell, ETTohen, MOlanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status. Int Clin Psychopharmacol 2002; 17 (5): 227–37.CrossRefGoogle ScholarPubMed
Small, JGKlapper, MHMarhenke, JDMilstein, VWoodham, GCKellams, JJLithium combined with carbamazepine or haloperidol in the treatment of mania Psychopharmacology Bulletin 1995; 31 (2): 265–72.Google ScholarPubMed
Soares, JCRecent advances in the treatment of bipolar mania, depression, mixed states, and rapid cycling. Int Clin Psychopharmacol 2000; 15(4): 183–96CrossRefGoogle ScholarPubMed
Stokes, PEShamoian, CAStoll, PMPatton, MJEfficacy of lithium as acute treatment of manic-depressive illness. Lancet 1971; 1 (7713): 1319–25.CrossRefGoogle ScholarPubMed
Suppes, TReview of the use of topiramate for treatment of bipolar disorders. J Clin Psychopharmacol 2002; 22 (6): 599–609.CrossRefGoogle ScholarPubMed
Swann, ACBowden, CLCalabrese, JRDilsaver, SCMorris, DDPattern of response to divalproex, lithium, or placebo in four naturalistic subtypes of mania. Neuropsychopharmacology 2002; 26 (4): 530–6.CrossRefGoogle ScholarPubMed
Tohen, MCastillo, JPope, HG JrHerbstein, JConcomitant use of valproate and carbamazepine in bipolar and schizoaffective disorders. J Clin Psychopharmacol 1994; 14 (1): 67–70.CrossRefGoogle ScholarPubMed
Tohen, MChengappa, KNSuppes, TZarate, CA JrCalabrese, JRBowden, CLet al.Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially non-responsive to valproate or lithium monotherapy. Arch Gen Psychiatry 2002; 59 (1): 62–9.CrossRefGoogle ScholarPubMed
Tohen, MJacobs, TGGrundy, SLMcElroy, SLBanov, MCJanicak, PGet al.Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzapine HGGW Study Group. Arch Gen Psychiatry 2000; 57 (9): 841–9.CrossRefGoogle Scholar
Tohen, MSanger, TMMcElroy, SLTollefson, GDChengappa, KNDaniel, DGet al.Olanzapine versus placebo in the treatment of acute mama. Olanzapine HGEH Study Group. Am J Psychiatry 1999; 156 (5): 702–9Google Scholar
Vaidya, NAMahableshwarkar, AShahid, RContinuation and maintenance ECT in treatment-resistant bipolar disorder. J ECT 2003; 19 (1): 10–6.CrossRefGoogle ScholarPubMed
Vieta, EHerraiz, MParramon, GGoikolea, JMFernandez, A Bena-barre, ARisperidone in the treatment of mania: efficacy and safety results from a large, multicentre, open study in Spain. J Affect Disord 2002:72(1): 15–19.CrossRefGoogle ScholarPubMed
Ward, RKZamorski, MABenefits and risks of psychiatric medications during pregnancy Am Fam Physician 2002; 66 (4): 629–36.Google ScholarPubMed
Werder, SFAn update on the diagnosis and treatment of mania in bipolar disorder. Am Fam Physician 1995; 51 (5): 1126–36.Google ScholarPubMed
Yatham, LNGrossman, FAugustyns, IVieta, ERavindran, AMood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial. Br J Psychiatry 2003; 182: 141–7.CrossRefGoogle ScholarPubMed
Zajecka, J MWeisler, RSachs, GSwann, ACWozniak, PSommer-ville, KWA comparison of the efficacy, safety, and tolerabihty of divalproex sodium and olanzapine in the treatment of bipolar disorder. Journal of Clinical Psychiatry 2002; 63 (12): 1148–55.CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.